Ciencia Labs delivers integrated discovery, biology, and chemistry solutions — advancing your pipeline with scientific rigor, speed, and uncompromising quality.
Ciencia Labs is a research-driven contract research organization providing end-to-end drug discovery solutions. We partner with biotech and pharma companies worldwide, leveraging deep scientific expertise to transform early-stage concepts into preclinical candidates with speed and precision.
Accelerated timelines without compromising quality
Regulatory-grade studies and documentation
PhD-level scientists across disciplines
Serving clients across North America, Europe & Asia
Science-Driven. From target to candidate — partnering with you at every milestone.
From target identification to IND-enabling studies, our comprehensive suite of services covers every stage of the drug discovery journey.
Design, synthesize, and optimize lead compounds with our experienced medicinal chemistry team.
Comprehensive biological profiling powered by robust in vitro and cell-based assay platforms.
AI-driven molecular design and computational modeling to accelerate your discovery pipeline.
Preclinical efficacy and safety studies designed to de-risk your candidates before clinical trials.
Tailored chemical synthesis from milligram to multi-gram scale for your research needs.
State-of-the-art analytical characterization and purification for compound quality assurance.
A structured, milestone-driven approach that brings transparency and efficiency to every project phase.
Computational target discovery, validation, and assay development for hit finding campaigns.
High-throughput screening, fragment-based approaches, and virtual screening to identify starting points.
Iterative design-make-test-analyze cycles to optimize potency, selectivity, and drug-like properties.
Preclinical development including GLP toxicology, CMC support, and regulatory package preparation.
Our clients choose Ciencia for our scientific depth, operational agility, and unwavering commitment to partnership.
Accelerated timelines powered by parallel workflows and dedicated project teams.
Rigorous data protection, confidentiality agreements, and secure infrastructure.
PhD-level expertise across chemistry, biology, and computational sciences.
FTE, FFS, or hybrid engagement models tailored to your project needs and budget.
Our multidisciplinary teams bring deep domain expertise in key disease areas.
Targeted therapies, immuno-oncology, and novel small molecule approaches for cancer.
Programs targeting heart failure, atherosclerosis, diabetes, and obesity.
Alzheimer's, Parkinson's, pain management, and neuroinflammation programs.
Antiviral, antibacterial, and antifungal drug discovery for emerging threats.
Autoimmune disorders, fibrosis, and inflammatory pathway modulation.
Specialized programs for underserved patient populations with unmet medical needs.